Marshall Wace, LLP 10x Genomics, Inc. Transaction History

Marshall Wace, LLP

  • $74.4 Billion
  • Q1 2025

A detailed history of Marshall Wace, LLP transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 417,451 shares of TXG stock, worth $3.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
417,451
Previous 46,861 790.83%
Holding current value
$3.41 Million
Previous $672,000 442.26%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$8.73 - $16.31 $3.24 Million - $6.04 Million
370,590 Added 790.83%
417,451 $3.64 Million
Q4 2024

Feb 13, 2025
SELL
$13.18 - $21.31 $5.54 Million - $8.96 Million
-420,262 Reduced 89.97%
46,861 $672,000
Q3 2024

Nov 14, 2024
BUY
$15.71 - $23.49 $6.78 Million - $10.1 Million
431,722 Added 1219.52%
467,123 $10.5 Million
Q2 2024

Aug 14, 2024
BUY
$19.45 - $37.37 $688,549 - $1.32 Million
35,401 New
35,401 $688,000
Q4 2023

Feb 14, 2024
BUY
$34.32 - $57.55 $257,949 - $432,545
7,516 New
7,516 $420,000
Q2 2023

Aug 14, 2023
BUY
$50.96 - $58.72 $10.1 Million - $11.6 Million
197,321 New
197,321 $11 Million
Q4 2022

Feb 14, 2023
BUY
$24.4 - $41.3 $470,139 - $795,768
19,268 New
19,268 $702,000
Q1 2022

May 16, 2022
SELL
$55.7 - $145.79 $540,512 - $1.41 Million
-9,704 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$135.05 - $182.59 $38.8 Million - $52.5 Million
-287,639 Reduced 96.74%
9,704 $1.45 Million
Q3 2021

Nov 15, 2021
BUY
$145.58 - $192.14 $43.3 Million - $57.1 Million
297,343 New
297,343 $43.3 Million
Q1 2021

May 17, 2021
SELL
$140.25 - $196.86 $36.1 Million - $50.6 Million
-257,149 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$126.47 - $163.7 $20.9 Million - $27.1 Million
165,325 Added 180.05%
257,149 $36.4 Million
Q3 2020

Nov 16, 2020
BUY
$87.44 - $125.0 $6.38 Million - $9.12 Million
72,924 Added 385.84%
91,824 $11.4 Million
Q2 2020

Aug 13, 2020
SELL
$58.39 - $89.31 $2.33 Million - $3.56 Million
-39,859 Reduced 67.83%
18,900 $1.69 Million
Q1 2020

May 15, 2020
BUY
$51.57 - $106.62 $3.03 Million - $6.26 Million
58,759 New
58,759 $3.66 Million

Others Institutions Holding TXG

# of Institutions
304
Shares Held
109M
Call Options Held
228K
Put Options Held
157K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $777M
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email